ResearcherIndiana University IndianapolisNo recent work listed

A. Jesse Gore

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6421-5084; OpenAlex author ID A5112503520. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2014: 2 papers

Papers 2

Pancreatic cancer-associated retinoblastoma 1 dysfunction enables TGF-β to promote proliferation. Co-author DOI 10.1172/jci71526 ↗
DUSP1 is a novel target for enhancing pancreatic cancer cell sensitivity to gemcitabine. First author DOI 10.1371/journal.pone.0084982 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Murray Korc · 2 shared papers, 2014 · strength 0.12
- Paper DUSP1 is a novel target for enhancing pancreatic cancer cell sensitivity to gemcitabine. DOI 10.1371/journal.pone.0084982 ↗
- Paper Pancreatic cancer-associated retinoblastoma 1 dysfunction enables TGF-β to promote proliferation. DOI 10.1172/jci71526 ↗
Fang Liu · 1 shared paper, 2014 · strength 0.06
- Paper DUSP1 is a novel target for enhancing pancreatic cancer cell sensitivity to gemcitabine. DOI 10.1371/journal.pone.0084982 ↗
Lakshmi Reddy Palam · 1 shared paper, 2014 · strength 0.06
- Paper Pancreatic cancer-associated retinoblastoma 1 dysfunction enables TGF-β to promote proliferation. DOI 10.1172/jci71526 ↗
Kelly E. Craven · 1 shared paper, 2014 · strength 0.06
- Paper Pancreatic cancer-associated retinoblastoma 1 dysfunction enables TGF-β to promote proliferation. DOI 10.1172/jci71526 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.